Micronase and Sinemet drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Micronase (glyburide) and Sinemet (carbidopa; levodopa). Common drug interactions include atrial fibrillation among females and hypotension among males.
The phase IV clinical study analyzes what interactions people have when they take Micronase and Sinemet. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Micronase?
Micronase has active ingredients of glyburide. eHealthMe is studying from 1,922 Micronase users. Check the latest studies of Micronase.
What is Sinemet?
Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13 people who take Micronase and Sinemet together, and have interactions are studied.

What are the common drug interactions of Micronase and Sinemet, by gender? *:
female:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
- Balance disorder
- Cardiac failure congestive
- Cardiac murmur (an heart sound in valve abnormality)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Cerebrovascular insufficiency (insufficient blood supply to brain)
- Chest pain
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
male:
- Hypotension (abnormally low blood pressure)
- Arthralgia (joint pain)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Intestinal obstruction
- Loss of consciousness
- Oesophagitis (inflammation of oesophagus)
- Platelet count decreased
- Pleural effusion (water on the lungs)
- Sedation
- Weakness
What are the common drug interactions of Micronase and Sinemet, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Hyperglycaemic hyperosmolar nonketotic syndrome (too much sugar (glucose) in your blood)
- Neuropathy peripheral (surface nerve damage)
- Type 1 diabetes mellitus
- Diabetes mellitus inadequate control
- Diabetic foot
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
- Diabetic retinopathy (damage to the retina caused by complications of diabetes)
- Hyperglycaemia (high blood sugar)
50-59:
- Weight decreased
60+:
- Cardiac failure congestive
- Pleural effusion (water on the lungs)
- Urinary tract infection
- Vomiting
- Weakness
- Abdominal discomfort
- Activated partial thromboplastin time prolonged
- Acute myocardial infarction (acute heart attack)
- Aggression
- Ammonia increased
What are the existing conditions these people have? *
- Stress And Anxiety: 2 people, 15.38%
- Sleep Disorder: 2 people, 15.38%
- Panic Disorder: 1 person, 7.69%
- Hypersensitivity: 1 person, 7.69%
- Headache (pain in head): 1 person, 7.69%
- Hallucinations (sensations that appear real but are created by your mind): 1 person, 7.69%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
- Delusion (a false belief or opinion): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Micronase and Sinemet?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Micronase and Sinemet:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Micronase:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sinemet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Micronase and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sinemet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on glyburide and carbidopa; levodopa (the active ingredients of Micronase and Sinemet, respectively), and Micronase and Sinemet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zyprexa Zydis and Symbicort - 3 seconds ago
- Could Pantoprazole Sodium cause Granuloma? - 8 seconds ago
- Famotidine and Zosyn drug interactions for women aged 30-39 - 13 seconds ago
- Drug interactions of Patanol and Fml Forte - 14 seconds ago
- Could Vitamin C cause Cerebral Haemorrhage? - 33 seconds ago
- Hydrocortisone and Pulmicort drug interactions for women aged 40-49 - 45 seconds ago
- Vitamin D and Crohns for Girls aged 10-19 - 53 seconds ago
- Vitamin D and Crohns Disease for Girls aged 10-19 - 53 seconds ago
- Vitamin D and Regional Enteritis for Girls aged 10-19 - 54 seconds ago
- Vitamin D and Inflammatory Bowel Disease - Crohn'S Disease for Girls aged 10-19 - 54 seconds ago